212 related articles for article (PubMed ID: 10921096)
1. [Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication].
Wu X; Wang Y; Pei X
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):16-9. PubMed ID: 10921096
[TBL] [Abstract][Full Text] [Related]
2. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
3. WT1 protein expression in childhood acute leukemia.
Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
[TBL] [Abstract][Full Text] [Related]
4. Expression of the Wilms' tumor gene (WT1) in human leukemias.
Miwa H; Beran M; Saunders GF
Leukemia; 1992 May; 6(5):405-9. PubMed ID: 1317488
[TBL] [Abstract][Full Text] [Related]
5. [Expression of WT1 gene in leukemia and its significance].
Wu X; Wang Y; Pei X
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):46-8. PubMed ID: 10921100
[No Abstract] [Full Text] [Related]
6. [Effect of WT1 gene expression on cell growth and proliferation in myeloid leukemia cell lines].
Mi Y; Wang L; Bian S
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):627-30. PubMed ID: 11263329
[TBL] [Abstract][Full Text] [Related]
7. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
Hämäläinen MM; Kairisto V; Juvonen V; Johansson J; Aurén J; Kohonen K; Remes K; Salmi TT; Helenius H; Pelliniemi TT
Eur J Haematol; 2008 Mar; 80(3):201-7. PubMed ID: 18081724
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome.
Busse A; Gökbuget N; Siehl JM; Hoelzer D; Schwartz S; Rietz A; Thiel E; Keilholz U
Ann Hematol; 2009 Dec; 88(12):1199-205. PubMed ID: 19404640
[TBL] [Abstract][Full Text] [Related]
9. [Genetic diagnosis of leukemia: diagnosis of relapse and complete remission, and prediction of leukemia onset].
Sugiyama H
Rinsho Byori; 2000 Feb; 48(2):155-61. PubMed ID: 10804819
[TBL] [Abstract][Full Text] [Related]
10. [Detection of WT1 expression in bone marrow of acute leukemia patients with real-time quantitative RT-PCR].
Gu WY; Chen ZX; Cao XS; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):728-31. PubMed ID: 15730716
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
12. [Individualized treatment of leukemia patients by monitoring of minimal residual disease (MRD) based on WT1 assay].
Ogawa H; Sugiyama H
Rinsho Ketsueki; 1998 Feb; 39(2):107-8. PubMed ID: 9545812
[No Abstract] [Full Text] [Related]
13. [Effect of WT1 antisense oligonucleotide on proliferation and apoptosis of human leukemia cells].
Wu X; Wang Y; Pei X
Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):631-3. PubMed ID: 11721364
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies.
Miyagawa K; Hayashi Y; Fukuda T; Mitani K; Hirai H; Kamiya K
Genes Chromosomes Cancer; 1999 Jun; 25(2):176-83. PubMed ID: 10338002
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia.
Barragán E; Cervera J; Bolufer P; Ballester S; Martín G; Fernández P; Collado R; Sayas MJ; Sanz MA
Haematologica; 2004 Aug; 89(8):926-33. PubMed ID: 15339675
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis.
Baird PN; Simmons PJ
Exp Hematol; 1997 Apr; 25(4):312-20. PubMed ID: 9131006
[TBL] [Abstract][Full Text] [Related]
17. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
[TBL] [Abstract][Full Text] [Related]
18. 5 Gy irradiation does not alter the expression level of WT1 (Wilms tumor gene) in K562 and ML1.
Yamazaki H; Tang JT; Koizumi M; Kagawa K; Inoue T; Imai A; Yoshida K; Shiomi H; Tanaka E; Nakamura H; Inoue T
Anticancer Res; 1998; 18(4A):2495-7. PubMed ID: 9703898
[TBL] [Abstract][Full Text] [Related]
19. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.
Østergaard M; Olesen LH; Hasle H; Kjeldsen E; Hokland P
Br J Haematol; 2004 Jun; 125(5):590-600. PubMed ID: 15147374
[TBL] [Abstract][Full Text] [Related]
20. Effect of WT1 gene expression on cell growth and proliferation in myeloid leukemia cell lines.
Mi Y; Wang L; Bian S; Meng Q; Chen G; Wang J
Chin Med J (Engl); 1999 Aug; 112(8):705-8. PubMed ID: 11601276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
